Neoplasm Proteins
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Subtype terms (5)
More specific conditions that are subtypes of Neoplasm Proteins in the MeSH hierarchy.
- Melanoma-Specific Antigens
- Myeloma Proteins
4 drugs approved
- Oncogene Proteins
19 drugs approved
- Tumor Protein, Translationally-Controlled 1
- Tumor Suppressor Proteins